0 items
Your cart is empty.
99.2% On-Time Delivery
Tracked International Shipping
Refund Within 28 Days
Secure, Encrypted Checkout
Each peptide batch is tested and verified to meet or exceed 98–99% purity (HPLC).
Store 2–8 °C (≤–20 °C long-term). RT exposure during transport acceptable. Protect from light.
99.2% On-Time Delivery
Tracked International Shipping
Refund Within 28 Days
Secure, Encrypted Checkout
$62.00
This product is available by prescription only
This product does not require a prescription
Out Of Stock
Each peptide batch is tested and verified to meet or exceed 98–99% purity (HPLC).
Store 2–8 °C (≤–20 °C long-term). RT exposure during transport acceptable. Protect from light.
The product is delivered in powdered (lyophilized) form and must be properly reconstituted prior to research use.
DSIP (delta-sleep-inducing peptide) is a nonapeptide — a nine-amino-acid chain — first characterized for its association with delta-wave electroencephalographic activity in preclinical models. Its structural profile has since been studied for interactions with multiple neuroendocrine systems, including the HPA axis, making it a relevant model compound for multi-pathway neurophysiological research. The defined molecular weight and sequence support precise dosing and reproducible experimental conditions.
Research using DSIP examines its modulatory activity on corticotropin (ACTH) and cortisol pathway signaling in preclinical models. Studies characterize its interaction with hypothalamic receptor systems and downstream neuroendocrine marker expression. This makes DSIP useful for laboratories investigating peptide-mediated modulation of HPA axis activity, stress hormone cascade dynamics, and feedback regulation mechanisms at the molecular level.
DSIP is studied in relation to circadian rhythm marker expression and delta-wave-associated signaling activity in controlled neurophysiological models. Researchers use it to examine the relationship between neuropeptide activity and oscillatory marker patterns, contributing to mechanistic understanding of peptide involvement in circadian regulatory pathways — without implying direct physiological outcome endpoints.
DSIP 10mg is manufactured by Elivena in USA GMP-certified facilities to approximately 99% purity, verified by independent third-party COA documentation. Each vial confirms peptide sequence identity and purity grade, providing laboratories with consistently characterized material for advanced neurophysiological and neuroendocrine research protocols.
DSIP 10mg is suited for research teams investigating neuropeptide signaling dynamics, hypothalamic-pituitary-adrenal (HPA) axis modulation, and circadian rhythm marker expression in preclinical models. Laboratories examining delta-wave-associated peptide activity, neuroendocrine interaction patterns, or corticotropin/ACTH pathway signaling will find this concentration appropriate for multi-month experimental designs. The 10mg format reduces vial turnover across extended protocols, supporting consistent peptide availability throughout the observation period. Produced by Elivena in USA GMP-certified facilities, each vial is COA-verified for purity and peptide sequence identity.
DSIP supports investigation of peptide-receptor interaction dynamics within the HPA axis. Researchers quantify ACTH and cortisol pathway marker activity, receptor occupancy patterns, and downstream signaling cascade responses in preclinical cell-based and in-vivo models. The 10mg concentration provides sufficient material for multi-phase mechanistic studies examining these neuroendocrine endpoints.
Laboratories studying circadian oscillation and peptide-associated marker expression use DSIP to examine the molecular relationship between neuropeptide activity and rhythm-associated signaling patterns. Research designs typically monitor endpoint expression at defined timepoints across extended observation windows to characterize temporal dynamics.
The 10mg vial format supports 12–24 week experimental designs, enabling systematic observation of neuropeptide signaling activity across multiple study phases. Higher concentration reduces logistical interruption between phases and supports reproducible, consistent peptide exposure throughout the protocol duration.
Reconstitute lyophilized DSIP 10mg with sterile bacteriostatic water using standard sterile laboratory technique. Reconstitution volume should be determined based on the target experimental concentration specified by the study design. Use calibrated laboratory equipment for all preparation steps.
Store lyophilized peptide at 2–8°C, protected from light and moisture, prior to reconstitution. Following reconstitution, maintain refrigeration at 2–8°C and use within the timeframe specified in the laboratory protocol. Lyophilized material does not require cold-chain shipping but should be refrigerated upon receipt. Each Elivena vial is supplied with COA documentation and handling guidance.
Novera Research delivers high-quality research peptides developed under strict manufacturing and quality-control standards. Each product is carefully synthesized, tested, and handled to ensure consistency, reliability, and transparency for advanced research applications.
High-purity, research-grade peptide synthesis
Analytical testing to verify quality and composition
Consistent batch-to-batch performance
Batch identification on every vial for traceability
Stored and shipped under controlled conditions
Tesamorelin 10mg is used to treat growth hormone deficiency and body composition concerns
Selective growth hormone secretagogue with minimal side effects and GH pulse stimulation. 10mg.
Short-acting GHRH analogue stimulating pulsatile growth hormone release. Research-grade, 10mg vial.
Copper-binding tripeptide promoting skin regeneration, wound healing, and anti-aging. 50mg vial.
